QIAGEN N.V. (QGEN) announced the exercising of the over allotment option by the underwriters for its offering of 27.5 million newly issued common shares, and purchasing of about 4.12 million common shares. The company will issue the additional shares at the price for the offering of US$20.25 per share or EUR 13.82.
The exercise of the over-allotment option brings the total number of common shares to be sold by the company in the offering to 31,625,000. Gross proceeds of the offering, including the additional shares, are expected to be about US$640 million or EUR 437 million.
The company plans to use the net proceeds of the offering to fund the acquisition of DxS Ltd. announced on September 22, 2009 and potential future acquisitions, to strengthen its balance sheet and for general corporate purposes.
Deutsche Bank, Goldman Sachs International and J.P. Morgan acted as Joint Global Coordinators and Joint Bookrunners of the offering.
For comments and feedback: editorial@rttnews.com